Browse all practice questions for the Regulatory Affairs Certification (RAC) Practice Exam. Search by topic, open any question and review its full explanation, then test yourself in the practice quiz.

Regulatory Affairs Certification (RAC) Practice Exam 2026 - Free RAC Practice Questions and Study Guide course image
Mastering the PMA: A Key Component of Regulatory AffairsIn regulatory affairs, what is the abbreviation for the application submitted for premarket approval?Demystifying Type B Meetings with the FDA: A Must-Know for RAC CandidatesWhich one of the following is NOT an example of a type B meeting with the FDA?Discover the Key Benefits of an Effective Document Control SystemWhich of the following is a benefit of maintaining an effective document control system?Enhancing Your Expertise as a Regulatory Affairs ProfessionalHow can regulatory affairs professionals enhance their expertise?Essentials of Submitting New Animal Toxicology Data to the FDAHow often should new animal toxicology data be submitted as an amendment after IND submission?Explore Career Paths in Regulatory AffairsWhich of the following career opportunities is available within regulatory affairs?Exporting Class III Medical Devices to Australia: Your Guide to ComplianceWhat regulatory action must a U.S. company take to export a Class III medical device to Australia?Fast Track Designation: A Game Changer in Drug DevelopmentWhat type of product designation provides incentives for developing drugs that treat serious conditions and fill an unmet medical need?Fast Track Designation: What Matters Most in Drug ApprovalWhat is considered a key factor in deciding whether to grant fast track designation for a drug?How Often Should You Update Your Investigator CV During an IND Study?How often is an investigator's Curriculum Vitae (CV) required to be updated during an IND study?Mastering FDA Requirements for Preclinical Drug StudiesWhat does FDA require regarding the preclinical studies of a new drug?Mastering Phase 3 Clinical Trials: What You Need to KnowWhat is the main goal of Phase 3 clinical trials?Mastering Sample Container Identification in Regulatory AffairsUpon receiving a raw material, what should be determined from the sample container identification?Mastering the Abbreviated 510(k): Understanding Relevant Consensus StandardsA manufacturer can submit an Abbreviated 510(k) based on which of the following?Navigating Clinical Trial Registries: What You Need to KnowWhich stage of clinical trials does NOT require inclusion in the clinical trial registry?Navigating Compliance: The Abbreviated 510(k) Submission for Class II DevicesWhat is the most suitable route of submission for a Class II device with electrical components?Navigating FDA Inspections for Class III Medical DevicesWhen should the manufacturer of a Class III medical device expect to have an FDA establishment registration inspection?Navigating FDA's Postmarketing Studies: What You Need to KnowUnder what circumstances can the FDA require a postmarketing study after product approval?Navigating Prescription Drug Labeling: What You Need to KnowWhich statement is true regarding labeling requirements for a prescription drug?Navigating Proprietary Name Approval for New DrugsWhich statement about proprietary name approval for a new drug is FALSE?Navigating Raw Data in Preclinical Studies: A Crucial Component of Regulatory AffairsWhich of the following is an example of raw data in a preclinical study?Navigating Regulatory Affairs: Key Differences in BLA and NDA RequirementsWhich of the following is NOT required in a Biologics License Application (BLA) but is required in a New Drug Application (NDA)?Navigating Regulatory Maze: Understanding Request for DesignationFor a medical device involving drug, biologic, and device components, what regulatory action should a company take if the product has not been classified by the FDA?Navigating Regulatory Options for OTC Monograph ModificationsWhat regulatory options can a company utilize for modifying an OTC monograph to market a new strength?Navigating Regulatory Waters: The Key First Step for Drug-Device CombinationsWhen uncertain about where to submit a marketing application for an unapproved drug-device combination product, what should a company submit first?Navigating the 90-Day Window for Special Protocol Assessments in Clinical TrialsWhat is the minimum time allowed to submit a request for a Special Protocol Assessment for a clinical trial?Navigating the 505(b)(2) Regulatory Pathway for Combination DrugsWhich regulatory pathway is most applicable for a combination of individually approved drugs with no Reference Listed Drug?Navigating the 510(k) Pathway for Medical Devices: A Simplified GuideFor a device substantially equivalent to one marketed before 1976, which regulatory path should a company follow?Navigating the 510(k) Submission Process for In Vitro Diagnostic TestsFor a 510(k) premarket notification for an in vitro diagnostic test, to whom should the firm submit the application?Navigating the Agreement Meeting: Your Key to Successful FDA CollaborationWhat is the term for the formal early collaboration meeting implemented by FDAMA?Navigating the FDA's Suitability Petition Process ExplainedWhat process should a sponsor use to apply for permission from the FDA for an ANDA that varies from the Reference Listed Drug (RLD) in route of administration, dosage form, or strength?Navigating the World of Biologics: Understanding CBER and Its RoleWhich FDA center regulates biologics, including vaccines and blood products?Regulatory Affairs Certification and License Revocation InsightsIn case a firm receives a report about serious adverse events, which factor is not considered a reason for a license revocation?Revising Labeling: The Key to Device Usage SuccessIf a device is failing frequently due to improper use, what action should be taken?The Crucial Role of Institutional Review Boards in Clinical TrialsWhat is the role of the Institutional Review Board in clinical trials?The Importance of a Complete Response Letter in FDA CommunicationWhat type of communication does FDA use when additional information is needed for an NDA or ANDA?The Importance of Auditor Independence in Quality System AuditsWhy does having only one internal auditor in a small company not meet the requirements for performing internal quality system audits?The Importance of Control Numbers in Medical DevicesProcedures for identifying the control number for each unit, lot, or batch of finished devices are required for which type of medical device?The Importance of Financial Disclosure in Research InvestigationsWho must disclose financial interests during an investigation?The Importance of Form FDA 483 in Preapproval InspectionsWhat document is discussed during a meeting after a deficiency is noted in a Preapproval Inspection?The Importance of Premarket Studies in FDA RegulationsWhat is a critical reason for conducting premarket studies according to FDA regulations?The Ins and Outs of Regulatory Compliance for Autologous Cellular TherapyWhat regulatory compliance must a company developing an autologous cellular therapy adhere to?The Role of Clinical Trials in Drug Safety and EfficacyWhat factor is critical in ensuring the safety and effectiveness of a new drug before it hits the market?Understand the FDA Review Process for New Medical DevicesWhich process allows a manufacturer to request FDA review of a new medical device?Understanding Adverse Event Reporting for Biologics: What You Need to KnowAdverse event reporting for a marketed biologics product is NOT required for:Understanding Bioequivalence in Suitability Petitions for ANDAsWhat is a key factor a sponsor must demonstrate in a Suitability Petition for an ANDA?Understanding CBER Regulations for Biological ProductsWhich biological product is NOT regulated by CBER?Understanding CDER's Role in Regulating Nasal Spray ProductsWhich FDA center is responsible for the regulation of a nasal spray single-entity combination product when a drug serves as its primary mode of action?Understanding Class III Medical Devices and Their Regulatory RequirementsWhich of the following statements about Class III medical devices is true?Understanding Compliance Requirements Under 21 CFR Part 11Which of the following is NOT required for compliance under 21 CFR Part 11 (electronic records and electronic signatures)?Understanding Deficiency Letters in Biologics License ApplicationsA deficiency letter may be issued during the review of a Biologics License Application (BLA) if:Understanding Design Validation in Clinical StudiesAccording to 21 CFR 820, how is a clinical study aimed at establishing device safety and effectiveness defined?Understanding Device Design Validation in Regulatory AffairsWhich element is NOT included as a requirement under device design validation according to the QSR?Understanding Distribution Records for Drug ProductsDistribution records for drug products must reference or contain:Understanding Expedited Review for Original Abbreviated New Drug ApplicationsWhich circumstance does NOT warrant expedited review of an Original Abbreviated New Drug Application?Understanding Fast Track Status for Investigational DrugsSenior management at your company asked you to develop a justification for fast track status for an investigational new drug for epilepsy. Which of the following would be an appropriate justification for FDA granting fast track status?Understanding FDA Approval for Generic DrugsIn order to be approved by FDA, a generic drug must be therapeutically equivalent to the branded product EXCEPT for:Understanding FDA Classifications: The Pacemaker Case StudyWhat classification is given to a new pacemaker once it begins marketing on the same day its PMA is mailed to the FDA?Understanding FDA Export Regulations for Medical DevicesA medical device may be exported under Section 801(e) of the Food, Drug, and Cosmetic Act provided that all the following apply for the device EXCEPT:Understanding FDA Inspection: What You Should KnowWhich of the following is NOT true for an FDA inspection of a manufacturing facility?Understanding FDA Postapproval Stability RequirementsWhat is NOT required by the FDA to support product postapproval stability requirements?Understanding FDA Regulations: What Makes a Device Adulterated?In what scenario would a device be considered adulterated under FDA regulations?Understanding FDA Submission Guidelines: Timing and Safety DataWhen must a company submit new safety information after an NDA submission?Understanding FDA's 90-Day Conference Post-NDA SubmissionAt what timeframe after submitting an NDA will FDA provide the organization with an opportunity to meet with agency reviewing officials to inform applicants of the general progress and status of their application?Understanding FDA's Regulation of Device AdvertisingWhat type of devices does the FDA regulate advertising for?Understanding FDA's Review Process for Generic Drug ApplicationsWhat does the FDA's Office of Generic Drugs prioritize when reviewing original ANDAs?Understanding FTC Authority in Drug AdvertisingThe Federal Trade Commission (FTC) has primary authority over which of the following?Understanding Good Manufacturing Practice and Its ImportanceWhat does “good manufacturing practice” or GMP entail?Understanding IND Applications and IDEs: A Guide for Regulatory Affairs StudentsWhich statement is NOT true regarding IND Applications and IDEs for significant-risk products?Understanding Investigator Disclosure Requirements for IND SubmissionsWhat information related to a clinical investigator who conducts Phase I pharmacokinetic studies must be disclosed with your IND submission if they receive a retainer for another product?Understanding IRB Approval for Pediatric Clinical TrialsWhat basis could an IRB use to approve a clinical trial involving children with no prospect of direct benefit?Understanding Medication Guides and Their Importance in Regulatory AffairsYour company recently submitted a Biologics License Application (BLA) to CDER and received a request to develop a Medication Guide. This request may have resulted from any of the following EXCEPT:Understanding Medication Guides: A Crucial Patient ResourceWhat is the primary purpose of a Medication Guide as requested by the FDA?Understanding Misbranding in Regulatory Affairs Through a Real-World ScenarioShould a surgeon's independent video of an investigational device on YouTube be considered misbranding?Understanding New Drug Applications and Biologics in Regulatory AffairsWhich type of products require a New Drug Application (NDA) for marketing approval?Understanding OTC Applications: A Guide for Sunscreen DevelopmentA company is planning to develop a sunscreen with an ingredient consistent with its published monograph for marketing within the US. What type of filing does the company have to submit?Understanding Patent Information Submission in Regulatory AffairsWhen is an applicant required to submit patent information in relation to a marketing application?Understanding Pathways for Combination Therapy ApprovalWhich pathway would NOT be appropriate for a combination therapy approval?Understanding Phase 1 Clinical Trials: The First Step to Safe Drug DevelopmentWhich stage is focused primarily on the safety, dosage, and side effects of a drug in human subjects?Understanding Phase 2 Clinical Trials for Cancer DrugsWhich factor is NOT appropriate for planning Phase 2 clinical trials for a novel cancer drug?Understanding Post-Market Surveillance and Its Importance in Regulatory AffairsWhat does the term “post-market surveillance” refer to?Understanding Pre-Market Regulatory Activities in the FDA Approval ProcessWhat is meant by "pre-market" regulatory activities?Understanding Regulatory Actions During a Class II Product RecallDuring a Class II product recall, what should a regulatory professional recommend if additional complaints arise?Understanding Regulatory Commitments: The Importance of Agreement MeetingsWhich of the following options represents a firm's commitment upon receiving an Agreement Meeting date?Understanding Regulatory Inspections: What You Need to Know for the RAC ExamWhich of the following is NOT a type of regulatory inspection for pharmaceutical products?Understanding Regulatory Oversight of Allergen Patch TestsWhich center should oversee the approval process for an allergen patch test?Understanding Regulatory Submissions for Medical DevicesWhich of the following is NOT a type of regulatory submission for medical devices?Understanding Reporting Requirements for FDA: Hypersensitivity Reactions DemystifiedIf a hypersensitivity reaction occurs that is not listed on your drug label, when should you report it to the FDA?Understanding Reserve Samples in Regulatory AffairsWhich of the following does NOT describe requirements for reserve samples?Understanding Special Protocol Assessment: What You Should KnowWhich type of protocol is NOT eligible for a Special Protocol Assessment review process with the FDA?Understanding Storage and Handling Requirements for Medical DevicesFor a medical device's storage and handling system, which of the following is NOT required by the manufacturer?Understanding Study Design in Pediatric Clinical TrialsWhich study design consideration is LEAST relevant when submitting a clinical study plan under the Pediatric Research Equity Act?Understanding Supplier Changes in OTC Monograph Drug ProductionHow should a company report the change of a supplier moving production of an OTC monograph drug substance?Understanding the 14-Day Timeline for SPL Submission in PharmaWhat is the preferred timeline for a pharmaceutical company to submit the Structured Product Labeling (SPL) formatted labeling upon product approval?Understanding the 505(b)(2) NDA Submission: What You Need to KnowA 505(b)(2) NDA is not an appropriate regulatory submission for the approval to market a:Understanding the 510(k) Submission in Regulatory AffairsWhat does 510(k) refer to in the regulatory process?Understanding the Balanced Presentation of Drug Benefits and Side EffectsWhat is the recommended approach for presenting drug benefits and side effects in advertisements?Understanding the Broad Scope of Labeling in Regulatory AffairsWhat is the meaning of “labeling” in regulatory terms?Understanding the Class III Device Assessment: Key Considerations for Regulatory ManagersWhat is the first consideration for a regulatory manager when assessing a new customer's Class III device impact?Understanding the Classification of Medical Devices: Class I, II, and III ExplainedWhat is the difference between a Class I, II, and III medical device?Understanding the Core Aspects of Effective Regulatory CommunicationWhich of the following is NOT a key aspect of effective regulatory communication?Understanding the Device History Record: Essential for Regulatory Affairs SuccessWhat is the provision for manufacturing reports on device manufacturing specifications by unit, lot, and batch under Quality System Regulation?Understanding the Drug Approval Process and Its SignificanceWhat is the primary purpose of the Drug Approval Process?Understanding the Essential Information in Product LabelingWhat type of information is included in product labeling?Understanding the Essential Role of Institutional Review Boards in Biomedical ResearchWhat is the primary role of Institutional Review Boards (IRBs)?Understanding the FDA's Fast Track Designation for Drug ApprovalWhat does “fast track” designation by the FDA signify?Understanding the FDA's Guidance on Combination ProductsWhat regulatory guidance provides a pathway for combination products?Understanding the FDA's Primary Responsibility for New Drugs and DevicesWhat is the primary legal responsibility of FDA regarding new drugs and devices?Understanding the FDA's Role in Medical Device MarketingWhich of the following best describes the role of the FDA in device marketing?Understanding the FDA's Role in Postmarket StudiesWhat role does the FDA play in regulating postmarket studies?Understanding the FDA's Unified Registration and Listing System for Medical DevicesHow does FDA require that all device registration and listing information be submitted?Understanding the Impact of Inactivity on Investigational New Drug ApplicationsAn Investigational New Drug Application goes inactive when which of the following occurs?Understanding the Impact of Regulatory Affairs Training on Employee SatisfactionWhat is one benefit of effective training programs in regulatory affairs?Understanding the Importance of Clinical Study Reports in Drug DevelopmentWhat does a Clinical Study Report (CSR) typically document?Understanding the Importance of Phase 3 Clinical TrialsWhat phase of clinical trials typically involves a larger number of patients to confirm efficacy and monitor side effects?Understanding the Importance of Quality Audits in Regulatory AffairsWhat is the main goal of conducting quality audits according to the Quality System Regulation?Understanding the Importance of Regulatory Inspections in the Pharmaceutical IndustryWhat is the significance of regulatory inspections in the pharmaceutical industry?Understanding the Importance of Submitting Prescribing Information in NDAsWhich document must be submitted alongside a New Drug Application for a new chemical entity?Understanding the Importance of Updated Labels for ConsumersWhy are updated labels important for consumers?Understanding the Key Documents in Medical Device ApprovalWhich document contains detailed information on the safety and effectiveness of a Class III medical device?Understanding the Preclinical Phase in Drug DevelopmentWhat is the primary goal of the preclinical phase of drug development?Understanding the Purpose of Phase 2 Clinical Investigations in Drug DevelopmentWhat is the main purpose of Phase 2 clinical investigations for a new drug?Understanding the Quality System Regulation for Medical Device ManufacturersWhich of the following is NOT part of the Quality System Regulation for manufacturers of finished devices?Understanding the Recall of Expired Medical Device ProductsWhat type of recall is the return of an expired medical device product categorized as?Understanding the Role of a Study Monitor in Clinical TrialsDuring a periodic visit to a clinical investigator, the study monitor should assure all of the following EXCEPT:Understanding the Role of the Institutional Review Board in IND ConsentsThe final authority for ensuring the adequacy of an Investigational New Drug (IND) informed consent document resides with the:Understanding the Role of the Investigational Plan in Clinical TrialsWhich document outlines the protocol for clinical trials?Understanding the Role of the Office of Combination Products in Regulatory AffairsA company developing a drug-device combination product should initially determine its primary mode of action (PMOA) through which entity?Understanding the Role of the Office of Prescription Drug PromotionWhat is the function of the Office of Prescription Drug Promotion (OPDP)?Understanding the Significance of a Warning Letter from the FDAWhat does a Warning Letter from the FDA indicate?Understanding the Three Phases of Clinical TrialsWhat are the three phases of clinical trials?Understanding Trade Secrets in Regulatory AffairsWhat does the term "trade secrets" refer to in a regulatory context?Understanding Type B Meeting Requests in Regulatory AffairsAll of the following would require a Type B Meeting request EXCEPT:Understanding User Fees in PMA Supplements: What You Need to KnowWhich Premarket Approval Application (PMA) supplements are NOT subject to user fee exemption?Understanding what CE marking signifies for medical devices in EuropeWhat does CE marking signify for medical devices in Europe?Understanding What Information is Required on Pharmaceutical Product LabelsWhat is typically included in the labeling of a pharmaceutical product?Understanding What's Not in Your Device Master RecordWhat is NOT included in the Device Master Record?Understanding When a Notice of Intent to Revoke is IssuedWhen can a Notice of Intent to Revoke be issued?Understanding When a Special 510(k) is Inappropriate for Device ModificationsIn which case would a Special 510(k) not be appropriate for a modified device?Understanding When CBER Submissions Are UnnecessaryIn which scenario does a company NOT need to submit to CBER?Understanding Who Holds the Responsibility for Regulatory ComplianceWho is ultimately responsible for ensuring regulatory compliance within an organization?Understanding why communication with stakeholders matters in regulatory affairsWhy is stakeholder communication important during regulatory affairs?What NDA Means in Regulatory Affairs and Its ImportanceIn the context of regulatory affairs, what does NDA stand for?What to Avoid After a Non-Approvable Vote from the FDA Advisory PanelWhich action should NOT be taken after receiving a vote of "non-approvable" from an FDA Advisory Panel?What You Need to Know About Accurate Claims in Drug LabelingWhat is a critical aspect of product labeling as defined in drug regulations?What You Need to Know About Premarket Approval Applications (PMA)Which of the following is NOT typically included in a Premarket Approval Application (PMA)?Why Electronic Records Matter Under 21 CFR Part 11What is the significance of maintaining electronic records under 21 CFR Part 11?Why Independent Audits are Key to Quality in Regulatory AffairsWhat element is crucial for establishing a quality system in regulatory affairs?Why Labeling Updates Matter in Ensuring Safe Product UseWhat is the significance of labeling updates during the product lifecycle?Why Training is Essential in Regulatory AffairsWhat role does training play in regulatory affairs?Your Pathway to Mastering the RAC Exam: Understanding Abbreviated 510(k) SubmissionsA medical device manufacturer is preparing a submission that requires a Declaration of Conformity with design control requirements. What type of submission is the manufacturer preparing to submit to FDA?
More practice questions

These questions are part of the practice quiz. Start practicing

  • In regulatory submission processes, what is the sponsor's primary responsibility?
  • What is one major goal of the FDA's pre-market review process?
  • Why are clinical trial phases important in drug development?
  • What is the role of the International Council for Harmonisation (ICH) in regulatory affairs?
  • What is the focus of post-market surveillance?
  • How does the regulatory pathway for orphan drugs differ?
  • What is one of the main purposes of post-market surveillance?
  • What is an essential part of preparing for a Pre-Submission meeting with the FDA?
  • How is the term "adverse event" defined in regulatory affairs?
  • What must labeling claims in marketing applications be supported by?
  • Which regulation serves as the foundation for drug regulation in the United States?
  • What does risk-benefit analysis assess in drug regulation?
  • What does IND stand for in a regulatory context?
  • What does compliance with regulatory standards primarily ensure?
  • What is the role of regulatory affairs professionals in the medical device industry?
  • What distinguishes a medical device from a drug?
  • What is the significance of the Common Technical Document (CTD)?
  • What is the primary purpose of regulatory affairs in the pharmaceutical and medical device industries?
  • Which regulatory body governs the approval of pharmaceuticals in the European Union?
  • What does Pre-market Approval (PMA) entail?
  • Which regulatory body is primarily responsible for the approval of combination products in the United States?
  • What is the role of quality assurance in regulatory affairs?
  • What does a proactive approach to risk management involve?
  • What is a dossier in regulatory affairs?
  • What is regulatory intelligence?
  • Which of the following is a requirement of product labeling regulations in the pharmaceutical industry?
  • What is a breakthrough therapy designation?
  • What is the function of a document control system in regulatory affairs?
  • What is the impact of inadequate labeling updates over time?
  • What is the primary goal of risk assessment in drug regulation?
  • What do regulatory agencies primarily monitor in post-market activities?
  • What does "confidentiality" mean in regulatory affairs?
  • What is the role of an authorized representative in regulatory affairs?
  • Which entity is responsible for overseeing prescription drug advertising?
  • Why is tracking and handling adverse events important?
  • What is the purpose of Risk Evaluation and Mitigation Strategies (REMS) in medication management?
  • Which is a key factor assessed during regulatory inspections?
  • Which agency is responsible for regulating drugs and biologics in the United States?
  • What key component does the Risk Management Plan (RMP) include?
  • What does a Pre-Submission meeting with the FDA involve?
  • What do labeling regulations primarily address?
  • What encompasses a risk management plan in regulatory contexts?
  • What does a Biologics License Application (BLA) represent?
  • What is the main focus during the registration phase of product development?
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy